Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

Ms. Lauren  Morris

Associate Director of Investors Relations

Mr. Reinilde  Heyrman M.D.

Chief Medical Officer of Medical Department

Ms. Susan E. Burwig BSN, MA

Executive Vice President of Operations

Mr. Jesse J. Geiger BBA, CPA

President

Mr. Kevin M. Brady

Chief Financial Officer & Treasurer

Mr. Stephen P. Ewald J.D.

Chief Compliance Officer, General Counsel & Corporate Secretary

Brandon  Ebken

Chief Information Officer

Mr. Todd  Meyers

Vice President of Business Development & Marketing

John T. Wynne MBA

Senior Vice President of Commercial Operations & Clinical Pharmacology Unit

Dr. August James Troendle M.D.

Chairman & Chief Executive Officer

Pavadinimas	Rinkos kapitalizacija
Revvity, Inc.	0M
China Biotech Services Holdings Limited	0M
IDEXX Laboratories, Inc.	0M
Yunkang Group Limited	0M
Standard BioTools Inc.	0M
Sonic Healthcare Limited	0M
Quest Diagnostics Incorporated	0M
Qiagen N.V.	0M
Amoy Diagnostics Co., Ltd.	0M
WuXi AppTec Co., Ltd.	0M
Shin Nippon Biomedical Laboratories, Ltd.	0M

Medpace Holdings, Inc.

Medpace Holdings, Inc. Konkurentų sąrašas

Pagrindiniai konkurentai